Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.08M Buy
5,733
+66
+1% +$22.6K 0.27% 53
2026
Q1
$1.99M Sell
5,667
-206
-4% -$73.4K 0.29% 50
2025
Q4
$1.92M Buy
5,873
+12
+0.2% +$3.81K 0.28% 52
2025
Q3
$1.65M Buy
5,861
+39
+0.7% +$11.3K 0.25% 54
2025
Q2
$1.63M Buy
5,822
+44
+0.8% +$12.5K 0.26% 50
2025
Q1
$1.8M Sell
5,778
-639
-10% -$189K 0.31% 47
2024
Q4
$1.62M Sell
6,417
-16
-0.2% -$4.75K 0.28% 47
2024
Q3
$2.07M Buy
6,433
+4
+0.1% +$1.31K 0.36% 41
2024
Q2
$2.01M Sell
6,429
-141
-2% -$41.4K 0.37% 40
2024
Q1
$1.87M Sell
6,570
-321
-5% -$93.9K 0.41% 39
2023
Q4
$1.98M Sell
6,891
-157
-2% -$42.8K 0.43% 36
2023
Q3
$1.89M Sell
7,048
-38
-0.5% -$9.48K 0.45% 33
2023
Q2
$1.57M Buy
7,086
+70
+1% +$16.2K 0.37% 39
2023
Q1
$1.7M Sell
7,016
-871
-11% -$214K 0.42% 36
2022
Q4
$2.07M Buy
7,887
+3
+0% +$804 0.71% 30
2022
Q3
$1.78M Buy
7,884
+229
+3% +$55.5K 0.6% 31
2022
Q2
$1.86M Buy
7,655
+50
+0.7% +$12.3K 0.62% 30
2022
Q1
$1.84M Buy
7,605
+137
+2% +$31.5K 0.51% 31
2021
Q4
$1.68M Buy
7,468
+78
+1% +$16.5K 0.47% 39
2021
Q3
$1.57M Buy
7,390
+63
+0.9% +$14.5K 0.47% 41
2021
Q2
$1.79M Buy
7,327
+72
+1% +$17.7K 0.53% 37
2021
Q1
$1.8M Buy
7,255
+5,455
+303% +$1.3M 0.57% 32
2020
Q4
$414K Buy
1,800
+20
+1% +$4.61K 0.13% 83
2020
Q3
$452K Sell
1,780
-220
-11% -$54.5K 0.17% 73
2020
Q2
$471K Buy
2,000
+7
+0.4% +$1.6K 0.17% 67
2020
Q1
$404K Sell
1,993
-20
-1% -$4.37K 0.16% 69
2019
Q4
$483K Buy
2,013
+10
+0.5% +$2.2K 0.16% 64
2019
Q3
$387K Buy
2,003
+11
+0.6% +$2.11K 0.14% 70
2019
Q2
$367K Sell
1,992
-15
-0.7% -$2.69K 0.13% 72
2019
Q1
$381K Sell
2,007
-330
-14% -$63K 0.14% 73
2018
Q4
$447K Buy
2,337
+13
+0.6% +$2.54K 0.19% 62
2018
Q3
$481K Buy
2,324
+12
+0.5% +$2.37K 0.19% 62
2018
Q2
$426K Buy
2,312
+334
+17% +$59.1K 0.17% 70
2018
Q1
$337K Buy
1,978
+10
+0.5% +$1.84K 0.14% 81
2017
Q4
$342K Buy
1,968
+19
+1% +$3.36K 0.15% 74
2017
Q3
$363K Buy
1,949
+28
+1% +$4.96K 0.17% 62
2017
Q2
$330K Buy
1,921
+10
+0.5% +$1.63K 0.17% 65
2017
Q1
$313K Sell
1,911
-116
-6% -$19.3K 0.17% 63
2016
Q4
$296K Buy
2,027
+8
+0.4% +$1.2K 0.17% 69
2016
Q3
$336K Buy
2,019
+132
+7% +$22.3K 0.19% 62
2016
Q2
$287K Buy
1,887
+31
+2% +$4.82K 0.16% 72
2016
Q1
$278K Buy
1,856
+6
+0.3% +$891 0.15% 77
2015
Q4
$300K Buy
1,850
+4
+0.2% +$629 0.13% 68
2015
Q3
$255K Buy
1,846
+6
+0.3% +$946 0.12% 74
2015
Q2
$282K Hold
1,840
0.13% 72
2015
Q1
$294K Hold
1,840
0.13% 74
2014
Q4
$293K Hold
1,840
0.14% 72
2014
Q3
$258K Hold
1,840
0.16% 90
2014
Q2
$218K Hold
1,840
0.25% 82
2014
Q1
$227K Hold
1,840
0.19% 78
2013
Q4
$210K Buy
1,840
+1,240
+207% +$141K 0.18% 80
2013
Q3
$67K Hold
600
0.07% 139
2013
Q2
$59K Buy
+600
New +$62.3K 0.09% 147

Other funds holding AMGN

Hudock Inc's AMGN Position: Q2 2026 in Review

Hudock Inc increased its Amgen (AMGN) stake by 1.2% in Q2 2026, buying an estimated $22.6K and bringing the position to 5,733 shares worth $2.08M. The position accounts for 0.27% of the portfolio, ranked #53.

Hudock Inc first reported a position in AMGN in Q2 2013 and has held it in 53 quarters since. 3,139 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • Hudock Inc held 5,733 shares of Amgen worth $2.08M as of Q2 2026.
  • Hudock Inc bought 66 Amgen shares in Q2 2026, an estimated $22.6K.
  • Amgen made up 0.27% of Hudock Inc's portfolio in Q2 2026, its #53 holding.
  • Hudock Inc first reported a position in Amgen in Q2 2013 and has held it in 53 quarters since.
  • 3,139 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Hudock Inc's 13F filing for Q2 2026, filed 31 Jul 2026.